Valneva SE (VALN) EBT Margin Growth (1y) (2022 - 2026)
Valneva SE (VALN) EBT Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | -8,536.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8,536.00 |
| Dec 31, 2025 | -6,900.00 |
| Sep 30, 2025 | -16,799.00 |
| Jun 30, 2025 | 4,151.00 |
| Mar 31, 2025 | -19,564.00 |
| Dec 31, 2024 | 376.00 |
| Sep 30, 2024 | 5,179.00 |
| Jun 30, 2024 | -1,481.00 |
| Mar 31, 2024 | 23,434.00 |
| Dec 31, 2023 | -2,444.00 |
| Sep 30, 2023 | -12,902.00 |
| Jun 30, 2023 | 15,016.00 |
| Mar 31, 2023 | 6,244.00 |
| Dec 31, 2022 | -10,565.00 |
| Sep 30, 2022 | 75,573.00 |
| Jun 30, 2022 | 3,611.00 |
| Mar 31, 2022 | 401.00 |